RecruitingPhase 2NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Sponsor: Daiichi Sankyo
Buffalo, NY · New York, NY · Valhalla, NY · +12 more sites
2 recruiting leukemia studies with a site in Westbury, NY.
Sponsor: Daiichi Sankyo
Buffalo, NY · New York, NY · Valhalla, NY · +12 more sites
Sponsor: Carna Biosciences, Inc.
Westbury, NY · +12 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.